These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8074604)

  • 41. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
    Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
    Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary and renal toxicity of intravenous immunoglobulin.
    Rault R; Piraino B; Johnston JR; Oral A
    Clin Nephrol; 1991 Aug; 36(2):83-6. PubMed ID: 1934664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperosmolarity Induces Armanni-Ebstein-like Renal Tubular Epithelial Swelling and Cytoplasmic Vacuolization.
    Zhou C; Vink R; Byard RW
    J Forensic Sci; 2017 Jan; 62(1):229-232. PubMed ID: 27787883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absence of osmotic nephrosis in renal tissue removed during laparoscopic nephrectomy after infusion of 6% Hydroxyethyl starch 130/0.4.
    Pinholt Kancir AS; Pleckaitis M; Ekeløf NP; Pedersen EB
    APMIS; 2015 Nov; 123(11):993-5. PubMed ID: 26495898
    [No Abstract]   [Full Text] [Related]  

  • 45. Oxytetracycline-induced nephrotoxicosis in dogs after intravenous administration for experimental bone labeling.
    Moalli MR; Dysko RC; Rush HG; Chrisp CE; Decoster JL; Sweet KA; Goldstein SA
    Lab Anim Sci; 1996 Oct; 46(5):497-502. PubMed ID: 8905581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies.
    Brannagan TH
    Neurology; 2002 Dec; 59(12 Suppl 6):S33-40. PubMed ID: 12499469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sucrose nephropathy "acute renal failure caused by intravenous immunoglobulin therapy".
    Renjen PN; Ahamed K; Kumar A
    J Assoc Physicians India; 2004 Oct; 52():840-1. PubMed ID: 15909869
    [No Abstract]   [Full Text] [Related]  

  • 48. [Lamellar cytoplasmic inclusions in the collecting tubules of the kidney in the course of osmotic nephrosis. Electron microscopical study].
    Melis M; Orci L
    Z Zellforsch Mikrosk Anat; 1967; 77(3):425-34. PubMed ID: 5598323
    [No Abstract]   [Full Text] [Related]  

  • 49. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
    Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M
    Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intravenous immunoglobulins and acute renal failure: mechanism and prevention].
    Fakhouri F
    Rev Med Interne; 2007 May; 28 Spec No. 1():4-6. PubMed ID: 17768831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drinking and renal responses to peripherally administered osmotic stimuli in the pigeon (Columbia livia).
    Thornton SN
    J Physiol; 1984 Jun; 351():501-15. PubMed ID: 6431086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute renal failure after intravenous immunoglobulin therapy.
    Pasatiempo AM; Kroser JA; Rudnick M; Hoffman BI
    J Rheumatol; 1994 Feb; 21(2):347-9. PubMed ID: 8182648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osmotic Nephrosis Induced by Water-Soluble Triiodinated Contrast Media in Man. A Retrospective Study of 47 Cases.
    Moreau JF; Droz D; Sabto J; Jungers P; Kleinknecht D; Hinglais N; Michel JR
    Radiology; 1975 May; 115(2):329-36. PubMed ID: 1096233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [On nephrotic lesions caused by sucrose].
    Corvilain J; Parmentier R
    Rev Belg Pathol Med Exp; 1956 Jul; 25(3):200-18. PubMed ID: 13379980
    [No Abstract]   [Full Text] [Related]  

  • 55. Not all intravenous immunoglobulin preparations are equally well tolerated.
    Feldmeyer L; Benden C; Haile SR; Boehler A; Speich R; French LE; Hofbauer GF
    Acta Derm Venereol; 2010 Sep; 90(5):494-7. PubMed ID: 20814625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case report: acute renal failure after administering intravenous immunoglobulin.
    Graumann A; Zawada ET
    Postgrad Med; 2010 Mar; 122(2):142-7. PubMed ID: 20203465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nephrotoxicity related to new therapeutic compounds.
    Szeto CC; Chow KM
    Ren Fail; 2005; 27(3):329-33. PubMed ID: 15957551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors.
    Sekul EA; Cupler EJ; Dalakas MC
    Ann Intern Med; 1994 Aug; 121(4):259-62. PubMed ID: 8037406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose containing intravenous immunoglobulins. A case-control study.
    Onuigbo MA
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):320-2. PubMed ID: 22238243
    [No Abstract]   [Full Text] [Related]  

  • 60. Ochratoxin A and citrinin induced nephrosis in Beagle dogs. III. Terminal renal ultrastructural alterations.
    Kitchen DN; Carlton WW; Hinsman EJ
    Vet Pathol; 1977 Jul; 14(4):392-406. PubMed ID: 560743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.